• Durvalumab-CRT Pairing Disappoints in Locally Advanced Cervical Cancer

    1 month ago - By MedPageToday

    NEW YORK - An immunotherapy-chemoradiotherapy combination did not boost progression-free survival in untreated, locally advanced cervical cancer, according to CALLA trial findings.
    Newly diagnosed patients who...
    Read more ...